Trial Profile
PHARMACOKINETICS AND PHARMACODYNAMICS IN THE OPTIMIZATION OF ANTIRETROVIRAL TREATMENT.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2012
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Efavirenz (Primary) ; Fosamprenavir (Primary) ; Lopinavir/ritonavir (Primary) ; Nevirapine (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics; Pharmacokinetics
- 31 Oct 2012 Planned End Date changed to 5 Jun 2009.
- 25 Oct 2012 New trial record